TrialAnnals of hematology1993
The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma. A phase-I study.
J M Raemaekers et al.PubMed ↗Publisher ↗
No numbers read from the abstract.